Peptide Workflow in action at Red Glead Discovery
Small Molecules and Synthetic Therapeutics
The articles contains an interview to Richard E. Johnsson, Ph.D., Head of Peptide Chemistry at Red Glead Discovery, Lund, Sweden, who ...
Small Molecules and Synthetic Therapeutics
The articles contains an interview to Richard E. Johnsson, Ph.D., Head of Peptide Chemistry at Red Glead Discovery, Lund, Sweden, who ...
Small Molecules and Synthetic Therapeutics
The number of equivalents used in a synthesis can significantly impact the cost of a peptide synthesis. Read more to learn how few ...
Small Molecules and Synthetic Therapeutics
Aspartimide rearrangements can negatively impact biological screening outcomes. Read more to learn methods to identify this side reaction ...
Small Molecules and Synthetic Therapeutics
Aspartimide rearrangements are one of the most ubiquitous side reactions encountered during solid phase synthesis. Read more to learn how ...
Small Molecules and Synthetic Therapeutics
Choosing a stationary phase seems relatively straightforward, almost automatic even. See how selectivity differences could impact your ...
Small Molecules and Synthetic Therapeutics
Sometimes closely eluting impurities are difficult to resolve by simply changing the gradient. Learn how ion pairing agents can help.
Small Molecules and Synthetic Therapeutics
Mass directed purification simplifies purification efforts. Read more how it can be used to reduce your purification time with flash ...
Small Molecules and Synthetic Therapeutics
In this blog, Beth highlights the role of of scavengers for peptides containing cysteine residues.
Small Molecules and Synthetic Therapeutics
Everyone asks about recovery when considering new strategies for peptide purification. Read more to learn about recovery when using flash ...
Small Molecules and Synthetic Therapeutics
Learn how acidic modifier concentration can impact your peptide purification with flash chromatography.